Margenza
Margetuximab-cmkb · TerSera Therapeutics LLC
CANCER MEDICINE · PRESCRIPTION ONLY (USA)Margenza ingredients
| Active ingredient | Strength |
|---|---|
| Margetuximab | 25 mg/mL |
What Margenza is used for
Margenza is a cancer medicine (her2/neu receptor antagonist). Its approved uses are listed on the official FDA label below.
Key facts
- Brand
- Margenza
- Generic name
- Margetuximab-cmkb
- Made by
- TerSera Therapeutics LLC
- Forms
- Injection, Solution, Concentrate
- Given
- Intravenous
- Drug class
- HER2/neu Receptor Antagonist
- FDA approval
- Biologic licence (BLA) BLA761150
- On the US market since
- 2021
Official information
- Margenza prescribing information (FDA label) on DailyMed
- MedlinePlus drug information (search for Margetuximab-cmkb)
Specialist medicine: started and supervised by a specialist doctor or hospital. This page is a plain-language summary of public official information, not medical advice; follow your doctor and the official product information.
Common questions
What is Margenza?
Margenza (Margetuximab-cmkb) is a cancer medicine made by TerSera Therapeutics LLC, approved by the US FDA.
What are the ingredients of Margenza?
Margenza contains Margetuximab (25 mg/mL).
From the FDA National Drug Code directory (open.fda.gov, public domain). Page made 5 November 2026 by Satya Babu.
← All specialty medicines, USA